Nitrovas SR Tablet (Sustained Release) 2.6 mg
Nitrovas SR Tablet (Sustained Release) 2.6 mg Uses, Dosage, Side Effects, Food Interaction and all others data.
| Trade Name | Nitrovas SR Tablet (Sustained Release) 2.6 mg |
| Generic | Nitroglycerin (Tablet) |
| Weight | 2.6 mg |
| Type | Tablet (Sustained Release) |
| Therapeutic Class | Nitrates: Coronary vasodilators |
| Manufacturer | Popular Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
Nitroglycerin is indicated for the prophylaxis of angina pectoris. The onset of action is not sufficiently rapid for this form to be useful in aborting an acute anginal episode.Dosage
Nitrovas SR Tablet (Sustained Release) 2.6 mg dosage
Dosage should always to be adjusted according to the requirement and response obtained by the individual patient and the severity of the anginal pain. For adults, one Nitroglycerin 2.6 mg sustained released tablet or capsule in morning and evening. This should be taken empty stomach.Side Effects
Headache may occur at the onset of treatment but will usually subside after a few days. If the headache persists dosage should be decreased. Other side effects include tachycardia, postural hypotension and syncope, cyanosis and methaemoglobinaemia.Precaution
Nitroglycerin should be used with caution in patients who are predisposed to closed-angle glaucoma. As with other drugs for the treatment of angina pectoris, abrupt discontinuation of therapy may lead to exacerbation of symptoms. When discontinuing long term treatment, the dosage should be reduced gradually over several days, and the patient carefully monitored. The use of nitroglycerin during the early days of acute myocardial infarction requires particular attention to hemodynamic monitoring and clinical status to avoid the hazards of hypotension and tachycardia.Interaction
Nitroglycerin dilates peripheral blood vessels and may increase the antihypertensive properties of vasodilators, calcium antagonists, beta-adrenergic blockers. Concomitant use of nitrates with tricyclic antidepressants and alcohol may cause high blood pressure. Concomitant use of nitrates with phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, vardenafil and tadalafil cause fall in blood pressure. Aspirin decreases the clearance and enhances the hemodynamic effects of nitroglycerin. Nitroglycerin may reduce the pharmacologic effects of heparin when used concomitantly. Nitrates increase the bioavailability of dihydroergotamine.Pregnancy & Breastfeeding use
There is no evidence relating to the safety of nitrates in pregnancy and lactation. Nitroglycerin should be administered to pregnant women and nursing mothers unless considered essential by the physician.Contraindication
Nitroglycerin is contraindicated in patients with a known hypersensitivity to nitroglycerin, other organic nitrates, or nitrites or to the excipients of the medicine. It is also contraindicated in patients with acute myocardial infarction, marked anaemia, head trauma, cerebral haemorrhage, or closed angle glaucoma.Acute Overdose
ln the case of overdosage, the likely symptomatology may be peripheral vasodilation with a fall in blood pressure and reflex tachycardia. In such an event, monitoring of cardiac function and general supportive measures should be used. If not successful, circulating plasma volume should be increased by substitution of fluid. ln life-threatening situations, administration of vasopressors should be considered.Storage Condition
Store in a cool and dry place away from light and heat. Keep all medicines out of the reach of children.Innovators Monograph
You find simplified version here Nitrovas SR Tablet (Sustained Release) 2.6 mg
